Cytoreductive radiotherapy combined with abiraterone in metastatic castration-resistance prostate cancer: a single center experience

BACKGROUND: To investigate the potential benefit of cytoreductive radiotherapy (cRT) in metastatic castration-resistant prostate cancer (mCRPC) patients receiving abiraterone. METHODS: From February 2014 to February 2019, 149 mCRPC patients treated with abiraterone were identified. Patients receivin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Radiat Oncol
Hauptverfasser: Liu, Yang, Long, Wen, Zhang, Zitong, Mai, Lixin, Huang, Sijuan, Liu, Boji, Cao, Wufei, Wu, Jianhua, Zhou, Fangjian, Li, Yonghong, He, Liru
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2021
Schlagworte:
Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7789459/
https://ncbi.nlm.nih.gov/pubmed/33407637
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-020-01732-y
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge